A study showed that serum CCL20 and IL‐17A levels were higher in CRC patients than those in healthy subjects, and the combination of CCL20 and IL‐17A signature curve analysis could differentiate CRC patients from healthy volunteers effectively.237. Here, CCL20 is linked to colorectal carcinoma.